Rheumatoid Arthritis Treatment Market Share

APAC Market Statistics

Regionally, the global rheumatoid arthritis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Asia Pacific industry is anticipated to hold largest revenue share by 2036, owing to increased research and development expenditure for rheumatoid arthritis by governmental agencies, and improving healthcare infrastructure in the region. The percentage of rheumatoid arthritis prevalence in APAC seems to be less than that in Europe and North America, the total number of rheumatoid arthritis patients in Asia is approximately 10 million, which poses a significant burden on the developing societies.

North America Market Analysis

 Furthermore, the rheumatoid arthritis treatment market in North America is evaluated to occupy the largest share in terms of revenue, in 2021 owing to the presence of various reimbursement policies, increasing awareness about the disease via support groups, and increasing adoption of physiotherapy. Moreover, the presence of major companies in the region and growing investment in therapies and novel drugs to treat rheumatoid arthritis, along with the increasing number of drugs in the pipeline and the growing clinical trials are expected to boost the market growth in the region, especially in the United States.